SpectraScience, Inc. (SCIE)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Inactive · Last trade price on Aug 26, 2025

SpectraScience Company Description

SpectraScience, Inc. develops and markets a technology platform to instantly determine whether a tissue is normal, pre-cancerous, or cancerous without the need for a physical biopsy in the United States, Europe, and internationally.

It offers WavSTAT3 optical biopsy system to determine whether a colon tissue is normal, pre-cancerous, or cancerous without physically removing tissue from the body; and WavSTAT4 optical biopsy system, a colon diagnostic product that operates by using UV laser light to optically illuminate and analyze tissue, enabling the physician to make an instant diagnosis during endoscopy when screening for cancer.

The company also sells mobile consoles and disposable forceps. In addition, it engages in developing an esophageal diagnosis application for the detection of pre-cancerous and cancerous tissues in various tissues of the body.

The company was formerly known as GV Medical, Inc. and changed its name to SpectraScience, Inc. in October 1992.

SpectraScience, Inc. was founded in 1983 and is based in San Diego, California.

SpectraScience, Inc.
CountryUnited States
Founded1983
IndustryMedical Devices
SectorHealthcare
Employees7

Contact Details

Address:
11568 Sorrento Valley Road
San Diego, Minnesota 92121
United States
Phone858 847 0200
Websitespectrascience.com

Stock Details

Ticker SymbolSCIE
ExchangeOTCMKTS
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberUS84760E3018
SIC Code3845

Key Executives

NamePosition
Lowell W. GiffhornChief Financial Officer and Secretary